Tag: CIRSE 2026
CIRSE 2026: Two-year trial results support sirolimus-eluting balloon for patients with...
Treatment with a sustained-release sirolimus-eluting balloon (SLR) for patients with failing arteriovenous fistulas (AVFs) was associated with higher target-lesion primary patency (TLPP) through to...
CIRSE 2026: STRIKE-PE subanalysis finds durable functional and quality-of-life outcomes for...
A subanalysis of the STRIKE-PE trial has provided evidence that treatment with the 16Fr Lightning Flash (Penumbra) computer-assisted vacuum thrombectomy (CAVT) device is associated...



